IL106755A0 - Therapeutic compositions and methods for inhibiting il-8-mediated inflammation - Google Patents

Therapeutic compositions and methods for inhibiting il-8-mediated inflammation

Info

Publication number
IL106755A0
IL106755A0 IL106755A IL10675593A IL106755A0 IL 106755 A0 IL106755 A0 IL 106755A0 IL 106755 A IL106755 A IL 106755A IL 10675593 A IL10675593 A IL 10675593A IL 106755 A0 IL106755 A0 IL 106755A0
Authority
IL
Israel
Prior art keywords
inhibiting
methods
therapeutic compositions
mediated inflammation
inflammation
Prior art date
Application number
IL106755A
Original Assignee
Scripps Research Inst
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst, Hadasit Med Res Service filed Critical Scripps Research Inst
Publication of IL106755A0 publication Critical patent/IL106755A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IL106755A 1992-08-21 1993-08-22 Therapeutic compositions and methods for inhibiting il-8-mediated inflammation IL106755A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93317192A 1992-08-21 1992-08-21

Publications (1)

Publication Number Publication Date
IL106755A0 true IL106755A0 (en) 1993-12-08

Family

ID=25463497

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106755A IL106755A0 (en) 1992-08-21 1993-08-22 Therapeutic compositions and methods for inhibiting il-8-mediated inflammation

Country Status (3)

Country Link
AU (1) AU5087393A (en)
IL (1) IL106755A0 (en)
WO (1) WO1994004173A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874080A (en) * 1994-03-03 1999-02-23 Genentech, Inc. Anti-IL-8 monoclonal antibodies for treatment of asthma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis

Also Published As

Publication number Publication date
WO1994004173A1 (en) 1994-03-03
AU5087393A (en) 1994-03-15

Similar Documents

Publication Publication Date Title
HK1094148A1 (en) Synergistic therapeutic compositions and methods
GB9208339D0 (en) Treatment composition
EP0695224A4 (en) Compositions and methods for waste treatment
ZA945653B (en) Therapeutic compositions
GB9219465D0 (en) Microbicidal compositions and methods
SG42865A1 (en) Therapeutic compositions and methods
IL107449A0 (en) Compositions and methods for reducing toxicity and increasing the efficacy of drugs
EP0531443A4 (en) Methods for treating inflammation and compounds and compositions suitable for use therein
GB2294637B (en) Therapeutic compositions and methods of use
GB9007730D0 (en) Therapeutic compound and composition
GB9220143D0 (en) Compounds and compositions
IL106755A0 (en) Therapeutic compositions and methods for inhibiting il-8-mediated inflammation
GB9220088D0 (en) Compounds and compositions
ZA935119B (en) Medicinal composition comprising TCF-II
HU9402308D0 (en) Pharmaceutical compositions and their use for treating zinc deficient disorders
AU4119993A (en) Heteroaroyl-10-deazaaminopterins for treatment of inflammation
EP0478660A4 (en) Pharmaceutical compositions and methods for treating inflammation
GB9326395D0 (en) Therapeutic methods and compositions
GB9211401D0 (en) Pharmaceutical method and compositions
GB9211399D0 (en) Pharmaceutical method and compositions
GB9211397D0 (en) Pharmaceutical method and compositions
GB9214591D0 (en) Therapeutic composition
GB9210644D0 (en) Therapeutic metal formulation
GB9217154D0 (en) Pharmaceutical compositions and their use
GB9123572D0 (en) Pharmaceutical compositions and methods for the treatment of malignancy